Literature DB >> 18796367

Retinoblastoma. Can we do more?

José Sánchez de Toledo.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18796367     DOI： 10.1007/s12094-008-0245-8

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  7 in total

1.  Red reflex examination in infants. Section on Ophthalmology. American Academy of Pediatrics.

Authors: 
Journal:  Pediatrics       Date:  2002-05       Impact factor: 7.124

Review 2.  Differential diagnosis of retinoblastoma.

Authors:  J A Shields; C L Shields; H M Parsons
Journal:  Retina       Date:  1991       Impact factor: 4.256

3.  Cancer screening practices of adult survivors of retinoblastoma at risk of second cancers.

Authors:  Victoria Sheen; Margaret A Tucker; David H Abramson; Johanna M Seddon; Ruth A Kleinerman
Journal:  Cancer       Date:  2008-07-15       Impact factor: 6.860

Review 4.  The retinoblastoma tumour suppressor in development and cancer.

Authors:  Marie Classon; Ed Harlow
Journal:  Nat Rev Cancer       Date:  2002-12       Impact factor: 60.716

5.  Relevance of CT and MRI in retinoblastoma for the diagnosis of postlaminar invasion with normal-size optic nerve: a retrospective study of 150 patients with histological comparison.

Authors:  Hervé J Brisse; Myriam Guesmi; Isabelle Aerts; Xavier Sastre-Garau; Alexia Savignoni; Livia Lumbroso-Le Rouic; Laurence Desjardins; François Doz; Bernard Asselain; Danièle Bours; Sylvia Neuenschwander
Journal:  Pediatr Radiol       Date:  2007-05-04

Review 6.  Molecular biology of retinoblastoma.

Authors:  C Sábado Alvarez
Journal:  Clin Transl Oncol       Date:  2008-07       Impact factor: 3.405

7.  Treatment of intraocular retinoblastoma with vincristine and carboplatin.

Authors:  Carlos Rodriguez-Galindo; Matthew W Wilson; Barrett G Haik; Thomas E Merchant; Catherine A Billups; Nirali Shah; Alvida Cain; James Langston; Mindy Lipson; Larry E Kun; Charles B Pratt
Journal:  J Clin Oncol       Date:  2003-05-15       Impact factor: 44.544
  7 in total
  1 in total

1.  In vitro evaluation of a targeted and sustained release system for retinoblastoma cells using Doxorubicin as a model drug.

Authors:  Sai H S Boddu; Jwala Jwala; Monica R Chowdhury; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2010-10       Impact factor: 2.671
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.